Concepedia

Plasminogen Activator System Localization in 60 Cases of Ductal Carcinoma In Situ

Thelma C. Hurd, Sheila N.J. Sait, Shin Kohga, Janet S. Winston, Maisie Martinick, Rakhee Saxena, Heather A. Lankes, Gabor Markus, Shashi R. Harvey, John F. Gibbs

Annals of Surgical Oncology · 2007 · 10 citations · 27 references

DOI

Concepts

References

27

Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer

D. Craig Allred, Gary M. Clark, Richard Elledge et al. · JNCI Journal of the National Cancer Institute · 1993 · 783 citations

, , +17

A prognostic index for ductal carcinoma in situ of the breast

Melvin J. Silverstein, Michael D. Lagios, Pamela H. Craig et al. · Cancer · 1996 · 705 citations · Full text

, , +17

Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

David L. Page, William D. Dupont, Lowell W. Rogers et al. · Cancer · 1995 · 433 citations · Full text

, , +13

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.

John A. Foekens, Harry A. Peters, Maxime P. Look et al. · PubMed · 2000 · 429 citations · Full text

, , +15

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.

J Grøndahl-Hansen, I. J. Christensen, Christian Rosenquist et al. · PubMed · 1993 · 390 citations

, , +13